Tech Company Financing Transactions
Tarveda Therapeutics Funding Round
Tarveda Therapeutics, operating out of Watertown, raised $5 million from private investors.
Transaction Overview
Company Name
Announced On
12/26/2013
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
134 Coolidge Avenue
Watertown, MA 02472
USA
Watertown, MA 02472
USA
Phone
Website
Email Address
Overview
Tarveda creates Pentarins that are targeted miniature drug conjugates that remain miniature by design to overcome the challenges that limit the efficacy of larger antibody drug conjugates in use and development today.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Drew Fromkin
Chief Medical Officer
Leila Alland
VP - Bus. Development
Sudha Kadiyala
VP - R & D
Richard Wooster
Browse more venture capital transactions:
Prev: 12/26/2013: Carmell Therapeutics venture capital transaction
Next: 12/26/2013: Healthsense venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs